Toronto-Dominion Bank »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 1.7M 1.41
2025-06-30 $3.0M 2.6M 1.14
2025-03-31 $2.1M 1.7M 1.28
2024-12-31 $541k 500k 1.08

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Cibc Cad (CM)
Tesla Motors (TSLA)
Amazon (AMZN)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
Spdr Gold Tr Gold Shs (GLD)
Bank Of Montreal Cadcom (BMO)
Meta Platforms Cl A (META)
Tc Energy Corp (TRP)
UnitedHealth (UNH)

View all positions for Toronto-Dominion Bank

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1